Our present study suggests that pre-administration of gastrin could attenuates kidney I/R injury via CCKBR to activate PI3K/Akt/Bad-mediated anti-apoptosis signaling (Figure 7), and gastrin might be a potential effective means to prevent AKI in clinic. This evidence concerns the gene BAD and acute kidney injury.